Rovedar was founded by Dr. Daryoush Babazadeh (DVM, DVSc, PhD) in 2021 as a non-profit and non-stock corporation in Türkiye (Company no. 0735181270300001; Tax No: 7351812703). Rovedar is a debt-free company and is not repaying loans or investments, but as a high-quality gold open-access publisher, it should pay for journal operations of newly established journals (15%), publication costs (10%), communication (5%), IT & innovation (12%), growth (16%), general & administration expenditure (5%), discounts and waivers (23%), differential article type pricing structure (2%), and general costs, such as membership in international publishing organizations and tax (12%). All revenues are generated from the author’s publication fees.
All manuscripts submitted to Rovedar journals are processed based on the ethics of the online peer-review process and open-access publication. Rovedar uses the potential of all scientific members to publish, share, and maximize the access and impact of the modern and latest knowledge of vital studies in all fields of science, especially veterinary science, medicine, and education. Moreover, the publisher follows the publication guidelines put forward by COPE and ICMJE. Some of the editors-in-chief and managing editors of Rovedar journals are members of World Association of Medical Editors (WAME) and endorses WAME members in the scientific, social, and environmental movements and policies.
As an open-access publisher listed in the Sherpa Romeo (Publisher ID: 64471). Rovedar entrusts the long-term preservation of its published content to Portico and Internet archive. Open Journal Systems (OJS) usually provide additional digital archiving and Rovedar journals are members of the Public Knowledge Project’s (PKP) LOCKSS network (PKP Preservation Network). Submission of a manuscript to a Rovedar journal implies that all authors have read and agreed to its content and that the manuscript conforms to the journal’s policies.
Rovedar is a member of Crossref (DOI prefix: 10.58803). The article contents of all Rovedar journals are fully uploaded on the Crossref website. All Rovedar journals have CrossMark logo, meaning that Rovedar is committed to maintaining the content it publishes and to alert readers to changes if and when they occur. On its way to disseminating scholarly knowledge, Rovedar is a member of CHORUS.
Mission and vision
Rovedar aims to publish high-quality open-access articles from international scientific societies, universities, and research institutes. Our mission is to disseminate knowledge and accelerate the seamless exchange of knowledge and scientific communication, fostering innovation and progress. At Rovedar, we envision a world where cutting-edge scientific knowledge is accessible to all, transcending borders and barriers. We strive to foster a global community where the latest advancements in various fields, particularly in veterinary science, medicine, and education, are disseminated freely and openly. Our vision is to empower researchers, scholars, and learners worldwide by providing a platform for high-quality open-access articles, ensuring that knowledge becomes a catalyst for positive change.
Authors who publish in Rovedar journals agree to the following terms:
a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
c. Authors are required to make sure submitted content does not infringe third-party copyright. Authors must obtain permission to reproduce any third-party material for online – and print, if applicable – publication in perpetuity. It is also the authors’ responsibility to include any acknowledgments requested by copyright holders, and to mark clearly third-party material used with permission, material that has separate licensing terms, and material used under exceptions or limitations to copyright.
Peer Review Policy
The practice of peer review is to ensure that only good science is published. It is an objective process at the heart of good scholarly publishing and is carried out by all reputable scientific journals. Our reviewers play a vital role in maintaining the high standards Review Policy and all manuscripts are peer-reviewed following the procedure outlined below.
Initial manuscript evaluation
The Editor first evaluates all manuscripts. It is rare, but it is possible for an exceptional manuscript to be accepted at this stage. Manuscripts rejected at this stage are insufficiently original, have serious scientific flaws, have poor grammar or English language, or are outside the aims and scope of the journal. Those that meet the minimum criteria are normally passed on to at least 2 experts for review.
Type of Peer Review
Rovedar journals employ a single-blind reviewing policy.
How the reviewer is selected
Whenever possible, reviewers are matched to the paper according to their expertise and our database is constantly being updated.
Reviewers are asked to evaluate whether the manuscript: – Is original – Is methodologically sound – Follows appropriate ethical guidelines – Has results which are clearly presented and support the conclusions – Correctly reviewers previous relevant work.
Language correction is not part of the peer-review process, but reviewers may, if so wish, suggest corrections to the manuscript.
How long does the review process take?
The time required for the review process is dependent on the response of the reviewers. Should the reviewers’ reports contradict one another or a report is unnecessarily delayed, a further expert opinion will be sought. The Editor’s decision will be sent to the author with recommendations made by the reviewers, which usually include verbatim comments by the reviewers. Revised manuscripts might be returned to the initial referees who may then request another revision of a manuscript.
A final decision to accept or reject the manuscript will be sent to the author along with any recommendations made by the reviewers and may include verbatim comments by the reviewers.
Editor’s Decision is final
Reviewers advise the editor, who is responsible for the final decision to accept or reject the article.
We are a ‘gold’ publisher. Rovedar publisher allows self-archiving and website archiving.
Rovedar entrusts the long-term preservation of its published content to Portico and Internet archive. Open Journal Systems (OJS) usually provide additional digital archiving and Rovedar journals are members of the Public Knowledge Project’s (PKP) LOCKSS network (PKP Preservation Network).
Authors may archive the final published version of their articles in personal or institutional repositories immediately after publication.
Statement of Informed Consent
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki. Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number. For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal. Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please also refer to the ICMJE Recommendations for the Protection of Research Participants. All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.
The articles in Rovedar journals are open-access.
By accessing this website, downloading, printing, or reading any article published in the Journal, you are stating that you agree to all of the following terms and conditions:
- In no event shall the Journal, its publisher, editors, or anyone involved in the journal be liable to you or any other party on any legal theory, for any special, incidental, consequential, punitive, exemplary, or any damages whatsoever arising out of or in connection with the use of any material in this web site or material published in the Journal, whether or not advised of the possibility of damage.
- The content of this website and the materials published in the journal are provided “as is” without warranty of any kind, either expressed or implied, including, but not limited to, the implied warranties of merchantability, fitness for a particular purpose, non-infringement, accuracy, completeness, or absence of errors.
- Statements or methods presented in the articles are those of the authors and do not constitute an endorsement by the editors or the publisher. The information contained in the articles must not be used as medical or any other advice. Nothing in the journal or on this website shall be deemed to be a recommendation of, endorsement of, or a representation as to a third party’s qualifications, services, products, offerings, or any other information or claim.
- The Journal reserves the right, at its sole discretion, to change the terms and conditions of this agreement at any time without notice and your access to this website will be deemed to be your acceptance of and agreement to any changed terms and conditions.
Rovedar does not allow commercial advertising in its journals.
Rovedar has a policy to allow anonymous reporting of any concerns about financial impropriety, corruption, or other serious problems at the organization. If you have such a concern, please report it at: firstname.lastname@example.org
Rovedar’s CrossMark Policy
CrossMark is a multi-publisher initiative to provide a standard way for readers to locate the authoritative version of an article or other published content. By applying the CrossMark logo, Rovedar is committing to maintaining the content it publishes and to alerting readers to changes if and when they occur.
Clicking the CrossMark logo on a document will tell you its current status and may also give you additional publication-record information about the document. The Rovedar content that will have the CrossMark logo is restricted to current and future journal content and is limited to specific publication types.
For more information on CrossMark, please visit the CrossMark site.
Rovedar is governed by its board, which is comprised of four external and four internal members representing Rovedar. Members serve 4-year renewable terms. The Rovedar board members generally have a broad range of expertise, knowledge, and interest in sustainable development goals regarding education, research, and high-quality publication. The Rovedar Foundation board meets annually to provide strategic guidance and on future programming and governance.
Key Management Staff
Atena Attaran, Managing Director of Publication Process and Ethics, IRAN
Atefeh Taherian Kalati, Manager of Language Department, CANADA
Ahmad Reza Mirzaei, Peer-review Manager, USA
Nefise Kandemir, Head of Financial Department, TURKIYE
Masoumeh Karimi, Technical Manager, IRAN